EXTON, Pa. (AP) — EXTON, Pa. (AP) — West Pharmaceutical Services Inc. (WST) on Thursday reported fourth-quarter profit of $130.1 million.
The Exton, Pennsylvania-based company said it had net income of $1.78 per share. Earnings, adjusted for restructuring costs, were $1.82 per share.
The results topped Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for earnings of $1.75 per share.
The medical device company posted revenue of $748.8 million in the period, also surpassing Street forecasts. Four analysts surveyed by Zacks expected $739.6 million.
For the year, the company reported profit of $492.7 million, or $6.69 per share. Revenue was reported as $2.89 billion.
West Pharmaceutical expects full-year earnings in the range of $6 to $6.20 per share, with revenue in the range of $2.88 billion to $2.91 billion.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on WST at https://www.zacks.com/ap/WST
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。